Variant LovD polypeptides and their uses
US-9546388-B2 · Jan 17, 2017 · US
Variant LovD polypeptides and their uses
US10590445B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10590445-B2 |
| Application number | US-201815899907-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 20, 2018 |
| Priority date | Sep 30, 2009 |
| Publication date | Mar 17, 2020 |
| Grant date | Mar 17, 2020 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present disclosure provides acyltransferases useful for synthesizing therapeutically important statin compound.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of making simvastatin comprising contacting monacolin J or lovastatin substrate with an isolated recombinant variant LovD polypeptide having at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 2, wherein the amino acid sequence of said LovD polypeptide comprises the substitution S172N, in the presence of an α-dimethylbutyryl thioester co-substrate and under conditions in which simvastatin is produced. 2. The method of claim 1 , wherein the monacolin J is a sodium salt. 3. The method of claim 2 , wherein the monacolin J is a sodium salt and activated charcoal is added. 4. The method of claim 1 , wherein the monacolin J is an ammonium salt. 5. The method of claim 4 , wherein an agent for precipitating simvastatin is added. 6. The method of claim 5 , wherein said agent is ammonium hydroxide. 7. The method of claim 1 , wherein said lovastatin substrate, said variant LovD polypeptide and said thioester are added at substantially the same time into a vessel. 8. The method of claim 7 , wherein said lovastatin substrate and said variant LovD polypeptide are first added into a vessel and then said thioester is added into said vessel. 9. The method of claim 1 , wherein an agent for precipitating simvastatin is added. 10. The method of claim 9 , wherein said agent is ammonium hydroxide.
Assignees
Inventors
Classifications
transferring groups other than amino-acyl groups (2.3.1) · CPC title
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof · CPC title
transferring groups other than amino-acyl groups (2.3.1) · CPC title
Acyltransferases (2.3) · CPC title
Carboxylic acid esters · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10590445B2 cover?
- The present disclosure provides acyltransferases useful for synthesizing therapeutically important statin compound.
- Who is the assignee on this patent?
- Codexis Inc
- What technology area does this patent fall under?
- Primary CPC classification C12P17/06. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).